ArticleBMC pulmonary medicine2025
Cryptogenic organizing pneumonia complicated by pulmonary embolism following glucocorticoid therapy: a case report.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundCryptogenic organizing pneumonia (COP), a rare interstitial lung disease, can mimic community-acquired pneumonia (CAP), often leading to delayed diagnosis. This case highlights the importance of recognizing COP in elderly patients and brings attention to pulmonary embolism (PE) as a potential but underrecognized complication associated with glucocorticosteroid therapy, providing novel insights into hypercoagulability risks during treatment. CASE PRESENTATION: An 80-year-old woman from Xinjiang presented with a 4-week history of cough, dyspnea, and weight loss that was unresponsive to antibiotics. Chest Computed tomography (CT) revealed bilateral subpleural consolidations with air bronchograms. Bronchoscopy ruled out infection, and a multidisciplinary evaluation confirmed COP based on clinical, radiological, and pathological correlation. Oral prednisone at 0.75 mg/kg/day led to symptom resolution within 14 days. However, during steroid tapering (10% weekly reduction), she developed hypoxemia at 3 months. CT angiography revealed segmental PE, despite the absence of conventional thrombosis risk factors. Treatment with anticoagulation and continued glucocorticoid therapy resulted in full recovery after 6 months.
conclusionsClinicians should consider COP in elderly patients with pneumonia unresponsive to antibiotics, confirm the diagnosis through biopsy, and remain vigilant for hypercoagulable states during glucocorticoid tapering. Anticoagulation should be tailored even in the absence of traditional thrombosis risk factors. The temporal association between steroid tapering and PE suggests that glucocorticoids may modulate endothelial function and coagulation pathways, highlighting the need for mechanistic studies to inform thromboembolic surveillance in COP management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.